Name Flags Card. Type Description & Constraints TreatmentSummary 0..* Base Treatment Summary subject 1..1 Subject Subject diagnosis 0..5 BackboneElement Diagnosis details 0..1 Diagnosis Details about this diagnosis frontLineTreatment 0..1 FrontLineTreatment Front line treatment chemotherapy 0..1 Chemotherapy Chemotherapy stemCellTransplantation 0..* StemCellTransplantation Stem Cell transplantation radiotherapy 0..* Radiotherapy Radiotherapy majorSurgery 0..* MajorSurgery Major Surgery otherInfos 0..* OtherInfos Other info and relevant events medicalSuggestion 0..1 string Medical suggestion relapseDuringFLT 0..* RelapseDuringFLT Progression-Relapse during FLT relapseAfterEOT 0..* BackboneElement Progression-relapse after the End of Treatment details 0..1 RelapseAfterFLT Details about this relapse-progression frontLineTreatment 0..1 FrontLineTreatment Salvage treatment notForRelapse 0..0 chemotherapy 0..1 Chemotherapy Chemotherapy stemCellTransplantation 0..* StemCellTransplantation Stem Cell transplantation radiotherapy 0..* Radiotherapy Radiotherapy majorSurgery 0..* MajorSurgery Major Surgery otherInfos 0..* OtherInfos Other info and relevant events medicalSuggestion 0..1 string Medical suggestion otherConditions 0..* string Other medical conditions, not cancer associated Documentation for this format
Treatment Summary data model Maturity Level: 2 - Ready for Review
TreatmentSummary model to PCSP HL7 FHIR R4 Profiles
All FHIR elements must have a @value or children
hasValue() or (children().count() > id.count())
Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.
Extensions are always sliced by (at least) url
Additional content defined by implementations
May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.
There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.
Must have either extensions or value[x], not both
exists(f:extension)!=exists(f:*[starts-with(local-name(.), "value")])
Extensions that cannot be ignored even if unrecognized
May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions. Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).
Modifier extensions allow for extensions that *cannot* be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the [definition of modifier extensions](http://hl7.org/fhir/R4/extensibility.html#modifierExtension).
Modifier extensions are expected to modify the meaning or interpretation of the element that contains them
Progression-Relapse during Front line treatment
Condition.conformsTo('http://hl7.eu/fhir/ig/pcsp/StructureDefinition/Condition-primaryCancer-eu-pcsp').where( (extension('http://hl7.eu/fhir/ig/pcsp/StructureDefinition/condition-previousStatus').valueCode = #replaspe or #recurrence) and ( onsetDateTime < Procedure.conformsTo('http://hl7.eu/fhir/ig/pcsp/StructureDefinition/Procedure-flt-eu-pcsp').performedPeriod.end) )
Progression-relapse after the End of Treatment
Condition.conformsTo('http://hl7.eu/fhir/ig/pcsp/StructureDefinition/Condition-primaryCancer-eu-pcsp').where( (extension('http://hl7.eu/fhir/ig/pcsp/StructureDefinition/condition-previousStatus').valueCode = #replaspe or #recurrence) and ( onsetDateTime >= Procedure.conformsTo('http://hl7.eu/fhir/ig/pcsp/StructureDefinition/Procedure-flt-eu-pcsp').performedPeriod.end) )
The salvage treatment has been executed following
2 => Trial/protocol 2 => Personalized 3 => Guidelines -9922 => NK
If a specific trial/protocol was used, please specify. In case of relapse/progression during front line treatment,please report both the name of the front line as well of the salvage treatment If personalized, please specify.
If the trial was randomized, please define randomization arm
It might be the date of first elective end of treatment, or that of the second (or further) end of treatment after the first one. If the date is unkown or partially missed insert the year at the best of your knowledge.
Procedure.conformsTo('http://hl7.eu/fhir/ig/pcsp/StructureDefinition/Procedure-surgery-eu-pcsp').exists().not() [No Case, implicit]
Procedure.conformsTo('http://hl7.eu/fhir/ig/pcsp/StructureDefinition/Procedure-surgery-eu-pcsp')..where(code = 'no-known-procedures').exists() [No Case, explicit]
Procedure.conformsTo('http://hl7.eu/fhir/ig/pcsp/StructureDefinition/Procedure-surgery-eu-pcsp').where(code != 'no-known-procedures' or code != 'no-procedure-info').exists() [Yes Case]
Procedure.conformsTo('http://hl7.eu/fhir/ig/pcsp/StructureDefinition/Procedure-surgery-eu-pcsp').where(code = 'no-procedure-info').exists() [Unk case]
Details not provided for relapses after EOT
Textual description in case of no remission
Progression/relapse during frontline treatment ?
Condition.conformsTo('http://hl7.eu/fhir/ig/pcsp/StructureDefinition/Condition-primaryCancer-eu-pcsp').where( (extension('http://hl7.eu/fhir/ig/pcsp/StructureDefinition/condition-previousStatus').valueCode = #replaspe or #recurrence) and ( onsetDateTime < Procedure.conformsTo('http://hl7.eu/fhir/ig/pcsp/StructureDefinition/Procedure-flt-eu-pcsp').performedPeriod.end) ).exists()
Progression/relapse after first elective end of treatment ?
Condition.conformsTo('http://hl7.eu/fhir/ig/pcsp/StructureDefinition/Condition-primaryCancer-eu-pcsp').where( (extension('http://hl7.eu/fhir/ig/pcsp/StructureDefinition/condition-previousStatus').valueCode = #replaspe or #recurrence) and ( onsetDateTime >= Procedure.conformsTo('http://hl7.eu/fhir/ig/pcsp/StructureDefinition/Procedure-flt-eu-pcsp').performedPeriod.end) ).exists()
Other medical conditions, not cancer associated
Please list here if the patient has or had other medical conditions not reported to be cancer-associated (e.g. diabetes, congenital cardiopathy, amputations, kidney transplant)